DexCom, Inc.
NASDAQ:DXCM
72.53 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | DexCom, Inc. |
Symbool | DXCM |
Munteenheid | USD |
Prijs | 72.53 |
Beurswaarde | 28,329,855,350 |
Dividendpercentage | 0% |
52-weken bereik | 62.34 - 142 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Kevin Ronald Sayer |
Website | https://www.dexcom.com |
An error occurred while fetching data.
Over DexCom, Inc.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)